Literature DB >> 19578080

In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008.

Samir N Patel, Dylan R Pillai, Sylvia Pong-Porter, Allison McGeer, Karen Green, Donald E Low.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19578080     DOI： 10.1093/jac/dkp231

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

Review 1.  Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

Authors:  Thomas P Lodise; Donald E Low
Journal:  Drugs       Date:  2012-07-30       Impact factor: 9.546

Review 2.  Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.

Authors:  James E Frampton
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

3.  In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.

Authors:  James A Karlowsky; Heather J Adam; Melanie R Decorby; Philippe R S Lagacé-Wiens; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

4.  Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Christopher Duplessis; Nancy F Crum-Cianflone
Journal:  Clin Med Rev Ther       Date:  2011-02-10

Review 5.  Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.

Authors:  Lindsay Kim; Lesley McGee; Sara Tomczyk; Bernard Beall
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.

Authors:  James A Karlowsky; Heather J Adam; Melanie R Baxter; Philippe R S Lagacé-Wiens; Andrew J Walkty; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

7.  Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections.

Authors:  Julian J Goodman; Stanley I Martin
Journal:  Ther Clin Risk Manag       Date:  2012-03-26       Impact factor: 2.423

8.  In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011.

Authors:  Karen Green; Allison McGeer; Wallis Rudnick; Sylvia Pong-Porter; Samir N Patel; Donald E Low
Journal:  Curr Microbiol       Date:  2014-07-15       Impact factor: 2.188
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.